Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
Sponsor: University of Alabama at Birmingham
Terminated
Inability to recruit patients that meet inclusion criteria.
Other terminated trials from University of Alabama at Birmingham
- Anal Incontinence · Phase PHASE4 · Feb 2026
- Respiratory Depression · May 2025
- Anaplastic Astrocytoma of Brain · Phase PHASE1 · Mar 2025
- Adult Cardiac Surgery · Nov 2024
- Contact Lens Complication · Phase PHASE4 · Aug 2024
See all terminations from University of Alabama at Birmingham
Other Coagulopathy trials with similar outcome
A PHASE2 clinical study on Coagulopathy and Nosocomial Pneumonia, this trial is terminated or withdrawn. The trial is conducted by University of Alabama at Birmingham and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Feb 2017 — May 2017 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alabama at Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .